Some doctorsat Memorial Sloan Kettering Cancer Center in 2012 refused to use Zaltrap, a new colon cancer drug, because it cost more than twice as much as a similar drug called Avatin as Zaltrap proved to be no better in terms of treatment outcomes than the cheaper Avatin.The doctors’ issues on this at Memorial Sloan Kettering worked, and the manufacturer of Zaltrap has since cut the price by half.
New Colon Cancer Issues
Previous post: Clean your Belly Button.
Next post: Drinking Cok & Soda-Beware.
Comments on this entry are closed.